BindingDB logo
myBDB logout

BDBM103777 US8551978, I-47::US8816088, I-47::US9394275, I-47::US9572802, Compound I-47::US9682957, I-47

SMILES: CC(Cc1ccc(CNC(=O)c2ccc(C)c(c2)N(C)C(=O)CCN2CCC(CC2)OC(=O)Nc2ccccc2-c2ccccc2)cc1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12

InChI Key: InChIKey=ODECJHUQVYAWEN-LYMXURKRSA-N

Data: 5 KI  2 EC50

Find this compound or compounds like it in BindingDB or PDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 7 hits for monomerid = 103777   
Target/Host
(Institution)
LigandTarget/Host
Links
Ligand
Links
Trg + Lig
Links
Ki
nM
ΔG°
kcal/mole
IC50
nM
Kd
nM
EC50/IC50
nM
koff
s-1
kon
M-1s-1
pHTemp
°C
Muscarinic acetylcholine receptor M3


(Homo sapiens (Human))
BDBM103777
PNG
(US8551978, I-47 | US8816088, I-47 | US9394275, I-4...)
Show SMILES CC(Cc1ccc(CNC(=O)c2ccc(C)c(c2)N(C)C(=O)CCN2CCC(CC2)OC(=O)Nc2ccccc2-c2ccccc2)cc1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12 |r|
Show InChI InChI=1S/C51H56N6O7/c1-33-13-18-38(50(62)53-31-36-16-14-35(15-17-36)29-34(2)52-32-46(59)41-19-21-45(58)49-42(41)20-22-47(60)55-49)30-44(33)56(3)48(61)25-28-57-26-23-39(24-27-57)64-51(63)54-43-12-8-7-11-40(43)37-9-5-4-6-10-37/h4-22,30,34,39,46,52,58-59H,23-29,31-32H2,1-3H3,(H,53,62)(H,54,63)(H,55,60)/t34?,46-/m0/s1
Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem

Similars

US Patent
0.200n/an/an/an/an/an/an/an/a



Theravance, Inc.

US Patent


Assay Description
Radioligand binding assay using muscarinic receptors.


US Patent US8551978 (2013)


BindingDB Entry DOI: 10.7270/Q2Q81BPC
More data for this
Ligand-Target Pair
Muscarinic acetylcholine receptor M3


(Homo sapiens (Human))
BDBM103777
PNG
(US8551978, I-47 | US8816088, I-47 | US9394275, I-4...)
Show SMILES CC(Cc1ccc(CNC(=O)c2ccc(C)c(c2)N(C)C(=O)CCN2CCC(CC2)OC(=O)Nc2ccccc2-c2ccccc2)cc1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12 |r|
Show InChI InChI=1S/C51H56N6O7/c1-33-13-18-38(50(62)53-31-36-16-14-35(15-17-36)29-34(2)52-32-46(59)41-19-21-45(58)49-42(41)20-22-47(60)55-49)30-44(33)56(3)48(61)25-28-57-26-23-39(24-27-57)64-51(63)54-43-12-8-7-11-40(43)37-9-5-4-6-10-37/h4-22,30,34,39,46,52,58-59H,23-29,31-32H2,1-3H3,(H,53,62)(H,54,63)(H,55,60)/t34?,46-/m0/s1
Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem

Similars

US Patent
0.200n/an/an/an/an/an/an/an/a



Theravance Respiratory Company, LLC

US Patent


Assay Description
Radioligand binding assays for cloned muscarinic receptors were performed in 96-well microtiter plates in a total assay volume of 100 uL. CHO cell me...


US Patent US8816088 (2014)


BindingDB Entry DOI: 10.7270/Q2TQ6068
More data for this
Ligand-Target Pair
Muscarinic acetylcholine receptor M3


(Homo sapiens (Human))
BDBM103777
PNG
(US8551978, I-47 | US8816088, I-47 | US9394275, I-4...)
Show SMILES CC(Cc1ccc(CNC(=O)c2ccc(C)c(c2)N(C)C(=O)CCN2CCC(CC2)OC(=O)Nc2ccccc2-c2ccccc2)cc1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12 |r|
Show InChI InChI=1S/C51H56N6O7/c1-33-13-18-38(50(62)53-31-36-16-14-35(15-17-36)29-34(2)52-32-46(59)41-19-21-45(58)49-42(41)20-22-47(60)55-49)30-44(33)56(3)48(61)25-28-57-26-23-39(24-27-57)64-51(63)54-43-12-8-7-11-40(43)37-9-5-4-6-10-37/h4-22,30,34,39,46,52,58-59H,23-29,31-32H2,1-3H3,(H,53,62)(H,54,63)(H,55,60)/t34?,46-/m0/s1
Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem

Similars

US Patent
0.200 -13.8n/an/an/an/an/an/a37



Theravance Respiratory Company, LLC

US Patent


Assay Description
Displacement assays for determination of Ki values of test compounds were performed with [3H]-NMS at 1 nM and eleven different test compound concentr...


US Patent US9394275 (2016)


BindingDB Entry DOI: 10.7270/Q2NS0SS8
More data for this
Ligand-Target Pair
Muscarinic acetylcholine receptor M3


(Homo sapiens (Human))
BDBM103777
PNG
(US8551978, I-47 | US8816088, I-47 | US9394275, I-4...)
Show SMILES CC(Cc1ccc(CNC(=O)c2ccc(C)c(c2)N(C)C(=O)CCN2CCC(CC2)OC(=O)Nc2ccccc2-c2ccccc2)cc1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12 |r|
Show InChI InChI=1S/C51H56N6O7/c1-33-13-18-38(50(62)53-31-36-16-14-35(15-17-36)29-34(2)52-32-46(59)41-19-21-45(58)49-42(41)20-22-47(60)55-49)30-44(33)56(3)48(61)25-28-57-26-23-39(24-27-57)64-51(63)54-43-12-8-7-11-40(43)37-9-5-4-6-10-37/h4-22,30,34,39,46,52,58-59H,23-29,31-32H2,1-3H3,(H,53,62)(H,54,63)(H,55,60)/t34?,46-/m0/s1
Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem

Similars

US Patent
0.200n/an/an/an/an/an/an/an/a



Theravance Respiratory Company LLC

US Patent


Assay Description
compounds were performed with [3H]NMS at 1 nM and eleven different test compound concentrations. The test compounds were initially dissolved to a con...


US Patent US9572802 (2017)


BindingDB Entry DOI: 10.7270/Q2VH5QWS
More data for this
Ligand-Target Pair
Muscarinic acetylcholine receptor M3


(Homo sapiens (Human))
BDBM103777
PNG
(US8551978, I-47 | US8816088, I-47 | US9394275, I-4...)
Show SMILES CC(Cc1ccc(CNC(=O)c2ccc(C)c(c2)N(C)C(=O)CCN2CCC(CC2)OC(=O)Nc2ccccc2-c2ccccc2)cc1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12 |r|
Show InChI InChI=1S/C51H56N6O7/c1-33-13-18-38(50(62)53-31-36-16-14-35(15-17-36)29-34(2)52-32-46(59)41-19-21-45(58)49-42(41)20-22-47(60)55-49)30-44(33)56(3)48(61)25-28-57-26-23-39(24-27-57)64-51(63)54-43-12-8-7-11-40(43)37-9-5-4-6-10-37/h4-22,30,34,39,46,52,58-59H,23-29,31-32H2,1-3H3,(H,53,62)(H,54,63)(H,55,60)/t34?,46-/m0/s1
Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem

Similars

US Patent
0.200n/an/an/an/an/an/an/an/a



Theravance Respiratory Company, LLC

US Patent


Assay Description
Radioligand binding assays for cloned muscarinic receptors were performed in 96-well microtiter plates in a total assay volume of 100 μL. CHO ce...


US Patent US9682957 (2017)


BindingDB Entry DOI: 10.7270/Q23776WR
More data for this
Ligand-Target Pair
Beta-2 adrenergic receptor


(Homo sapiens (Human))
BDBM103777
PNG
(US8551978, I-47 | US8816088, I-47 | US9394275, I-4...)
Show SMILES CC(Cc1ccc(CNC(=O)c2ccc(C)c(c2)N(C)C(=O)CCN2CCC(CC2)OC(=O)Nc2ccccc2-c2ccccc2)cc1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12 |r|
Show InChI InChI=1S/C51H56N6O7/c1-33-13-18-38(50(62)53-31-36-16-14-35(15-17-36)29-34(2)52-32-46(59)41-19-21-45(58)49-42(41)20-22-47(60)55-49)30-44(33)56(3)48(61)25-28-57-26-23-39(24-27-57)64-51(63)54-43-12-8-7-11-40(43)37-9-5-4-6-10-37/h4-22,30,34,39,46,52,58-59H,23-29,31-32H2,1-3H3,(H,53,62)(H,54,63)(H,55,60)/t34?,46-/m0/s1
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem

Similars

US Patent
n/an/an/an/a 3n/an/an/a25



Theravance Respiratory Company, LLC

US Patent


Assay Description
cAMP assays were performed in a radioimmunoassay format using the Flashplate Adenylyl Cyclase Activation Assay System with [125I]-cAMP (NEN SMP004, P...


US Patent US9682957 (2017)


BindingDB Entry DOI: 10.7270/Q23776WR
More data for this
Ligand-Target Pair
Beta-2 adrenergic receptor


(Homo sapiens (Human))
BDBM103777
PNG
(US8551978, I-47 | US8816088, I-47 | US9394275, I-4...)
Show SMILES CC(Cc1ccc(CNC(=O)c2ccc(C)c(c2)N(C)C(=O)CCN2CCC(CC2)OC(=O)Nc2ccccc2-c2ccccc2)cc1)NC[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12 |r|
Show InChI InChI=1S/C51H56N6O7/c1-33-13-18-38(50(62)53-31-36-16-14-35(15-17-36)29-34(2)52-32-46(59)41-19-21-45(58)49-42(41)20-22-47(60)55-49)30-44(33)56(3)48(61)25-28-57-26-23-39(24-27-57)64-51(63)54-43-12-8-7-11-40(43)37-9-5-4-6-10-37/h4-22,30,34,39,46,52,58-59H,23-29,31-32H2,1-3H3,(H,53,62)(H,54,63)(H,55,60)/t34?,46-/m0/s1
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem

Similars

US Patent
n/an/an/an/a 3n/an/an/a37



Theravance Respiratory Company, LLC

US Patent


Assay Description
cAMP assays were performed in a radioimmunoassay format using the Flashplate Adenylyl Cyclase Activation Assay System with [125I]-cAMP (NEN SMP004, P...


US Patent US9394275 (2016)


BindingDB Entry DOI: 10.7270/Q2NS0SS8
More data for this
Ligand-Target Pair